<DOC>
	<DOCNO>NCT00929409</DOCNO>
	<brief_summary>200 patient post partum anemia randomise receive either intravenous iron ( intervention group ) peroral iron ( control group ) . The hypothesis intravenous iron supplementation superior standard peroral iron .</brief_summary>
	<brief_title>Controlled Randomised Trial Ferric Carboxymaltose Oral Iron Treat Postpartum Anemia</brief_title>
	<detailed_description>The study multi center phase 3 trial , comprise 3 medium size obstetrical unit Norway . The amount iron give intervention group calculate accord modify Ganzoni formula . The control group give standard regime 200 mg ferro sulphate daily . In group , treatment start inclusion , within 48 h delivery . The sample size base power calculation : About 200 participant require detect difference 0.5 g/dl group ( 80 % power ) . Randomization perform use opaque envelope . An electronic CRF apply . Laboratory analysis provide recognize Swedish biochemical laboratory . Apart hemoglobin common iron parameter , serum concentration soluble ferritin receptor analyze , well hepcidin level .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Depression , Postpartum</mesh_term>
	<mesh_term>Puerperal Disorders</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>Woman within 48 h post partum Hemoglobin level equal high 6.5 g/dl equal low 8.5 g/dl Able read understand Norwegian language Signed informed consent Anemia attributable iron deficiency Contraindications study drug Treatment drug , dietary supplement natural remedy contain iron Clinically significant condition opinion investigator disqualify patient study Assessed require blood transfusion ( )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Postpartum anemia , iron-deficiency</keyword>
</DOC>